AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
64 hedge funds and large institutions have $32.6M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 66 → 64 (-2)
29% less call options, than puts
Call options by funds: $313K | Put options by funds: $439K
Holders
64
Holding in Top 10
1
Calls
$313K
Puts
$439K
Top Buyers
| 1 | +$405K | |
| 2 | +$320K | |
| 3 | +$227K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$206K |
| 5 |
AWS
AJ Wealth Strategies
New York
|
+$105K |
Top Sellers
| 1 | -$408K | |
| 2 | -$297K | |
| 3 | -$79K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$75K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$64K |